War, sanctions and inflation leave Iran short of hundreds of medicines
Source: Euronews ↗ (cross-verified by 2 outlets — full list below)
Iran’s pharmaceutical sector is confronting a severe crisis as the war with the United States enters its seventh month, compounded by sanctions, a naval blockade and a sharp depreciation of the rial. Prices for basic medicines have surged dramatically—paracetamol up 375%, amoxicillin 285%, gabapentin 220% and insulin up to six times its previous cost—while shortages now affect roughly 90 essential or life‑saving drugs and an estimated 400 medicines that are produced domestically but rely on imported raw materials. More than 70% of healthcare expenses are paid out of pocket, leaving many patients unable to afford treatment, and the shortage has been exacerbated by attacks on 44 companies in the medicines and medical equipment sector, including the missile‑hit firm Tofigh Daru, which was accused—though it denies—of supplying fentanyl for non‑medical purposes.
The root of the crisis lies in disrupted supply chains caused by the U.S. naval blockade imposed in April, the brief lift and subsequent reinstatement of that blockade, and the broader “Operation Economic Outcast” launched in late August to cut Tehran’s access to international financial networks. Even though humanitarian goods like medicines are formally exempt from sanctions, banking restrictions and difficulties in transferring foreign currency have prevented Iranian firms from purchasing essential raw materials abroad. Iranian officials, including Hadi Ahmadi of the Pharmacists Association and MP Ruhollah Lak Aliabadi, note that imported inputs are now bottlenecked, with some shipments stalled in transit and others forced onto longer, riskier routes, such as those through Shanghai, further inflating costs and delaying production.
The impact on the population is stark: patients with chronic conditions such as diabetes, heart disease and cancer are forced to abandon or delay treatment due to unaffordable prices, a trend observed by MPs Ahmad Ariayi Nejad and Salman Es’haghi, who report declining clinic attendance and the financial strain of routine injections costing tens of millions of tomans—equivalent to several months’ wages for many. While Tehran claims that the industry remains operational and that some shortages have eased, the combination of price hikes, supply chain breakdowns and direct attacks on pharmaceutical facilities suggests a prolonged humanitarian challenge that could deepen health inequities and exacerbate the nation’s broader economic crisis.
⚡ Effects Interpreter
🌍World Economylow impact
What this means for you
- ▶World markets have a habit of reading between the lines of stories like this.
- ▶Overseas suppliers might gradually rethink their pricing after news like this.
🏙️Local Economylow impact
What this means for you
- ▶Your local economy has a way of catching these currents eventually.
- ▶Local wages and hours worked might bend slightly with the wider trend.
🏦Rates & Bankslow impact
What this means for you
- ▶Any move in rates would probably come later, not overnight.
- ▶Interest rates and mortgage bills are unlikely to jump straight away from this alone.
❤️Healthlow impact
What this means for you
- ▶Vulnerable groups may want extra reassurance from a trusted source.
- ▶Peace of mind typically starts with reliable information.
💷Wealthhigh impact
What this means for you
- ▶A modest emergency fund can cushion any health-related costs.
- ▶Your budget may feel a slight health-related nudge over time.
🏠Housingmedium impact
What this means for you
- ▶Local surveyors often note that sentiment shifts before prices actually do.
- ▶Property values usually need more than one headline to really move.
🌍 Effects for your country
The U.S.'s central bank rate currently stands at 3.75%, so a global rates move like this could feed through to local borrowing costs. The U.S.'s economy is growing at 2.3% with inflation at 3.2%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the U.S.'s own central bank rate closely. With the U.S.'s unemployment at 4.4%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in the U.S. depends more on local healthcare capacity than the figures above.
The UK's central bank rate currently stands at 3.75%, so a global rates move like this could feed through to local borrowing costs. The UK's economy is growing at 0.8% with inflation at 3.2%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the UK's own central bank rate closely. With the UK's unemployment at 5.6%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in the UK depends more on local healthcare capacity than the figures above.
France's central bank rate currently stands at 2%, so a global rates move like this could feed through to local borrowing costs. France's economy is growing at 0.9% with inflation at 1.8%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track France's own central bank rate closely. With France's unemployment at 7.9%, personal-finance effects like this land on a labour market that is already under strain. Health-system effects are harder to localise from economic indicators alone — the real impact in France depends more on local healthcare capacity than the figures above.
Romania's central bank rate currently stands at 6.5%, so a global rates move like this could feed through to local borrowing costs. Romania's economy is growing at 0.7% with inflation at 7.8%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track Romania's own central bank rate closely. With Romania's unemployment at 6%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in Romania depends more on local healthcare capacity than the figures above.
The UAE's central bank rate currently stands at 3.65%, so a global rates move like this could feed through to local borrowing costs. The UAE's economy is growing at 3.1% with inflation at 2.5%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the UAE's own central bank rate closely. Health-system effects are harder to localise from economic indicators alone — the real impact in the UAE depends more on local healthcare capacity than the figures above.